We, however, conclude that targeting ATM in SKOV3 is a potential important strategy in disrupting ovarian cancer proliferation, and overexpressing RYBP may offer new avenues for inhibiting ATM activity. This evidence concerns the gene RYBP and ovarian carcinoma.